Okamoto Yoshiaki, Tsuneto Satoru, Morita Tatsuya, Takagi Tatsuya, Shimizu Megumi, Miyashita Mitsunori, Uejima Etsuko, Shima Yasuo
1 Palliative Care Team, Department of Pharmacy, Ashiya Municipal Hospital, Hyogo, Japan.
2 Department of Palliative Medicine, Kyoto University Hospital, Kyoto, Japan.
Am J Hosp Palliat Care. 2017 Apr;34(3):248-253. doi: 10.1177/1049909115626701. Epub 2016 Jul 10.
The aims of this study are to clarify the state of information regarding opioids for families and what kinds of experiences they had with opioids while the patient was followed as an outpatient and inpatient.
This study was part of a cross-sectional nationwide survey of bereaved families of patients with cancer, namely, the Japan Hospice and Palliative Care Evaluation 2 study. The participants in this study comprised 572 bereaved families who had experienced the death of a family member during the period from January 2008 to December 2009 at 1 of 103 certificated palliative care units.
In response to the question of "how much improvement was needed for information regarding opioids," 41% answered "improvement is not necessary at all," 43% answered "improvement is slightly necessary," 14% answered "improvement is necessary," and 2% answered "improvement is extremely necessary." Regarding anxiety about the use of opioid, it was found that 14% of respondents indicated "opioids are very safe," 65% of respondents indicated "opioids are relatively safe," 19% of respondents indicated "opioids are not so safe," and 2% of respondents indicated "opioids are not so safe at all." from the information obtained for opioids. It was found that 90% of families agreed with the item, "I would like to be clearly explained that drugs for medical purposes are safe and that the patient will not develop a drug addiction and their life expectancy will not be reduced."
From this study, it is important for families of patients with cancer to be explained profound and careful information of opioid.
本研究旨在阐明家庭关于阿片类药物的信息状况,以及在患者作为门诊和住院患者接受随访期间,他们在阿片类药物方面有何种经历。
本研究是对癌症患者 bereaved 家庭进行的全国性横断面调查的一部分,即日本临终关怀与姑息治疗评估 2 研究。本研究的参与者包括 572 个 bereaved 家庭,这些家庭在 2008 年 1 月至 2009 年 12 月期间,在 103 个认证的姑息治疗单位中的 1 个经历了家庭成员的死亡。
对于“阿片类药物信息需要多大程度的改进”这一问题,41%的人回答“完全不需要改进”,43%的人回答“略有改进的必要”,14%的人回答“有改进的必要”,2%的人回答“极其有改进的必要”。关于对使用阿片类药物的焦虑,从所获得的阿片类药物信息中发现,14%的受访者表示“阿片类药物非常安全”,65%的受访者表示“阿片类药物相对安全”,19%的受访者表示“阿片类药物不太安全”,2%的受访者表示“阿片类药物完全不安全”。发现 90%的家庭同意这一项目,“我希望能得到清楚的解释,即用于医疗目的的药物是安全的,患者不会染上毒瘾,并且他们的预期寿命不会缩短。”
从本研究来看,向癌症患者家属解释阿片类药物的深入且细致的信息很重要。